TJC0434
Solid tumor oncology
PreclinicalActive
Key Facts
About TaiwanJ Pharmaceuticals
TaiwanJ develops small‑molecule drugs for liver and inflammatory diseases using proprietary TLR4/Autotaxin platforms.
View full company profileTherapeutic Areas
Other Solid tumor oncology Drugs
| Drug | Company | Phase |
|---|---|---|
| Sanoosa‑002 | Sanoosa | Preclinical |
| CIK Cell Immunotherapy | Cytopeutics | Phase 1 |